DAFTAR PUSTAKA
American Society of Health System Pharmacists. 2011. AHFS Drug Information. United States of America. Anil, K., Gopala & Prameela. 2014. A concise review on oral pH independent controlled drug delivery system. World J Pharmacy Pharmaceu Sci, 3, 11, 311-324. Arking, R. 1998. Biology of aging: observations and priciples (2 nd ed.). Sunderland: Sinauer Associate Publisher. Arnata, A., Noor, C. & Difa, I. 2014. Prevalensi kejadian berpotensi interaksi obat pada pasien ICU di RSUD Ulin Banjarmasin tahun 2012. J Pharmasci, 1, 1: 28-34. Askgaard, D.S., Wilcke, T. & Dossing, M. 1995. Hepatotoxicity caused by the combined action of isoniazid and rifampicin. Thorax, 50, 213-214. Baxter, K. 2008. Drug interactions (8th ed.). London: Pharmaceutical Press. Bartelink, A.K.M., Lenders, J. W. M. , van Herwaarden, C. L. A. 1983. Fatal hepatitis after treatment with isoniazid And rifampicin in a patient on anticonvulsant therapy, Tubercle, 64, 125-128. Bhadbadhe, S. 2015. Aging and periodontium. Int J Dentistry Oral Sci, 2, 6, 7983. Bushra, R., Nousheen, A. & Arshad, Y.K. 2011. Food drug interactions. Oman Med J, 26, 2, 77-83. Christina., Umi, A., Mufarrihah & Yunita, N. 2014. Drug therapy problems pada pasien yang menerima resep polifarmasi, Jurnal Farmasi Komunitas, 1, 1, 17-22. Chrysostomou, A., Eugenia, P., Lachlan, M.G & Gavin, J.B. 2006. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long term angiostensin-converting enzyme inhibitor therapy, with or without an angiostensin II receptor blocker. Clin J Am Soc Nephrol,1:256262. Direktorat Bina Farmasi Komunitas dan Klinik. 2004. Pedoman Pelayanan Farmasi (Tata Laksana Terapi Obat) Untuk Pasien Geriatri. Jakarta: Departemen Kesehatan RI, 1, 57.
Doll, R. 1995. Chronic and degenerative disease: major causes of morbidity and death. Am J Clin Nutr, 62, 1, 1301S-5S. Gallagher, P., Barry & Mahony. 2007. Inappropriate prescribing in the elderly, J Clin Phar Therapeu. 32, 113-121. Gallegos, JF., Amy EF, Susan MS & Stoa RN. 2012. Chronic constipation in the elderly. Am J GastroEntero, 107, 18-25. Gilman, A.G. 2007. Goodman and Gilman Dasar Farmakologi Terapi, edisi 10. Vol. 2, 48: 1247-1253, Diterjemahkan oleh Tim Ahli Bahasa Sekolah Farmasi ITB. Penerbit Buku Kedokteran. Gitawati, R. 2008. Interaksi obat dan beberapa implikasinya. Media Litbang Kesehatan XVIII, No.4, 175-184. Gluidice, A.D., Matteo, P., Gluseppe, V., Michele, P., Chiara, D.G. & Flippo, A. 2012. Acute kidney injury in the elderly: epidemiology, risk factors and outcomes. J Nephrol Therapeut, 2, 6, 1-8. Goel, R. & Vedi, A. 2015. Xerostomia: a common problem of the geriatric population. Int J Advanced Res, 3, 2, 52-56. Hajjar, E.R., Cafiero, A.C., & Hanlon, J.T. 2007. Polypharmacy in elderly patients, Am J of Ger Pharmacotherapy, 5, 4, 345-351. Handayani, K. 2015. Skripsi: Analisis potensi interaksi obat diabetes melitus pada resep obat pasien rawat jalan di RSAL Mintohardjo. Jakarta: Fakultas Kedokteran dan Ilmu Kesehatan Prodi Farmasi UIN Syarif Hidayatullah. Harjai, K.J., Nunez, E., Turgut, T., & Newman, J. 2001. Effect of combined aspirin and angiotensin converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure. Am J Cardiol, 87, 483-487. Harjai, K.J., Solis, S., Prasad, A. & Loupe, J. 2003. U se of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure. Int J Cardiol, 88, 207–214. Harugeri, A., Joseph, G., Parthasarathi, M., Ramesh & S. Guido. 2010. Potentially inappropriate medication use in elderly patients: a study prevalence and predictors in two teaching hospitals. J Postgrad Med, 56, 3, 186-191. Induri, M., Bhagavan, R., & Rajendra, P. 2012. Validated and stability indicating liquid chromatography method for quantification of bisoprolol fumarate in tablet dosage form. Int J Pharm, 2(1): 64-70.
Iskandar, H., Wahyudi, U.H., Yetti, H., & Syamsudin. 2012. A retrospective study on the potential drug interaction between angiostensin converting enzyme inhibitor or angiostensin receptor antagonist and other drugs in end stage chronic renal failure patients. Int Res J Phar, 3, 10: 86-89. Kementrian Kesehatan RI. 2013. Jendela data dan informasi kesehatan: gambaran kesehatan lanjut usia di Indonesia. Buletin, ISSN 2088-270X, 1-16. Kumara, S., Jignesh, U.R., Bushipaka, R., Mehul, R., B, Sowmya & Dhruvil, P. 2014. Prevalence of polypharmacy and drug to drug interactions in a tertiary care teaching hospital. Int Res J Pharm, 5,10, 778-782. Kwan, D. & Farrel, B. 2014. Polypharmacy optimizing medication use in elderly patients. CGS J CME, 4, 1, 21-26. Lima, R.E.F.& Cassiani, S.H.B, 2009. Potential Drug Interactions In Intensive Care Patients At ATeaching Hospital. Rev Latino-am Enfermagem; 17(2): 222-7 Lindri, R.M. 2013. Skripsi: Analisis terapi polifarmasi pada pasien gagal jantung kongestif di IRNA Jantung RSUP Dr. M. Djamil Padang. Fakultas Farmasi Universitas Andalas. Majeed, A.A. 2010. Oral and peroral physiological changes with aging. Pakistan Oral Dental J, 30, 1, 26-30. Martindale, W. 2009. Martindale: the extra pharmacopoeia, 27th edition. The Pharmaceutical Press: London. Martono, H. 2009. Buku ajar geriatri (ilmu kesehatan usia lanjut). Jakarta: Balai penerbit Fakultas Kedokteran Universitas Indonesia. McConnell., Hala, M.F. & Abdul, W.B. 2008. Explorations in intestinal physiology and drug delivery. Int J Pharmaceu, 366, 213-226. Myoung, S.C., Ho, Y. L. & Chin, S. C. 2014. Optimal dosage of methylprednisolone for thetreatment of sudden hearing loss in geriatric patients:A propensity score-matched analysis. Int J Pharm ,9 (11). Nasrallah, S.N & Raymond, R. 2012. Insulin degludec, the new generation basal insulin or just another basal insulin?. Clin Med Insights: Endocrinology and Diabetes, 5. Ningsih. 2004. Skripsi: Interaksi obat pada pasien di poliklinik geriatri perjan RS Dr. Cipto Mangunkusumo. Jakarta: UIN Syarif Hidayatullah.
Nobili, A., Silvio, G. & Pier, M.M. 2011. Multiple disease and polypharmacy in the elderly: challenges for the internist of the third millenium. J Comorbid, 1, 28, 28-44. Notoatmojo, S. 2002. Metodologi penelitian kesehatan. Jakarta: Penerbit PT. Rineka Cipta. OHTA, M. 2009. Management of anemia in the elderly. J M A J, 52, 4, 219-223. Olivari, M. T., Cesare, B., Alvise, P.,Cesare, F.., Paolo, M., & Maurizio, D. 1979. Treatment of hypertension with nifedipine, a calcium antagonistic agent, J Circulation 59, No. 5. Raghavendra, M. & Vidya, M.J. 2013. Function of kidney and artificial kidneys. Int J Innov Res, 1, 1. Rahmawati, F., Dewa, P.M., Wasilah, R. & Syed, A.S. 2009. Polypharmacy and unnescessary drug therapy on geriatric hospitalized patients in Yogyakarta Hospital Indonesia. Int J Pharm Sci, 1, 1. Restalita. 2010. Skripsi: Evaluasi Interaksi Obat Pada Peresepan Pasien Lanjut Usia di Puskesmas Pancoran Mas Kota Depok. Depok. Rambadhe, S. 2012. A survey on polypharmacy and use of inappropriate medications. Toxicol Int, 1, 19, 68-73. Kementrian Kesehatan. 2012. Riset Kesehatan Dasar. Jakarta: Badan LitBang Kesehatan RI. Romana, A., Laxminarayana, K., Astha, S., Susma, M. & Jayanthi, C.R. 2012. Polypharmacy leading to adverse drug reaction in elderly in a tertiary care hospital, Int J Pharm Biosci, 218-224. Salter, E.K., Maura, W. & Miguel, A.P. 2014. Early exposure to geriatric care: Developing undergraduate internship in ethics and geriatric practice. Int J Med Ed, 5, 15-17. Schepkens, H., Vanholder, R., Billiouw, J.M. & Lameira, N. 2001. Lifethreatening hyperkalemia during combined therapy with angiotensinconverting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med, 110, 438-441. Schmucker, D.L. 1998. Aging and the liver: An update. J Geront Bio Sci, 53, 5, B315-B320. Soherwardi, S., Bharti, C., & Faizal, P. 2012. Surveillance of the potential drugdrug interactions in the medicine department of a tertiary care hospital. J Clin Diagnos, 6,7: 1258-1261.
Syamsudin. 2011. Interaksi obat konsep dasar dan klinis. Jakarta: Penerbit Universitas Indonesia Press. Tatro, D. S. 2008. Drug Interaction Facts, 2nd ed. Fact and Comparisons. St. Louis: A Wolters Kluwer Company. Toison, D., Yves, R., Sandrine, A., Jean, P.A., John, B., Athanase, B., Gilles, B., Laura, C.P., Birong, D., Francoise, F., Alain, F., Simon, F., Antoni, S., Daniel, S., Marco, T., Bruno, V. & Ladislav, V. 2011. International association of gerontology and geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc, 12: 184-189. Undang-Undang Republik Indonesia No.13 Tahun 1998 tentang kesejahteraan manusia, Bab I, Pasal 1: ayat 2,3,4. Viktil, K.K., Hege, S.B., Tron, A.M. & Aasmund, R. 2006. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol, 63, 2, 187-192. Weathermon, R. & David, W.C. 1999. Alcohol and medication interactions. Alcohol Res Health, 23,.1, 41-52.
